Featured in Newslaundry on July 25th 2017
While Toxoplasma causes long-lasting infections that resist treatment, research on this neglected parasite promises to unveil new ways to treat malaria. But there is more to this microbe than meets the eye. Listen to our podcast to find out.
References:
General introduction
TORCH member
CDC assigned category NPI
Early research and establishment as parasite: Ferguson, David JP. “Toxoplasma gondii: 1908-2008, homage to Nicolle, Manceaux and Splendore.” Memórias do Instituto Oswaldo Cruz 104.2 (2009): 133-148.
Use of the Sabin-Feldman test to find Toxoplasma infections worldwide
The life cycle of Toxoplasma
Toxoplasmosis as zoonosis
Studies in India to measure Toxoplasma infection
Concerns about sexual transmission of Toxoplasma (here and here)
Malaria in India (Searo, NCBI, NCBI, WHO)
Resistance of malaria to standard medication
Whitehead Institute’s use of CRISPR on Toxoplasma
Apicomplexans
Crippling host invasion protein CLAMP (here and here)
Aid to research on inflammation
No obvious symptoms of Toxoplasma infection in otherwise healthy people
Eye infections by Toxoplasma
Toxoplasma and neurological disorders (here and here)
Immunosuppression by HIV or by medical treatments, leading to reactivation of Toxoplasma (here and here )
Toxoplasmosis in organ transplant recipients
Organ transplantation related diseases (here and here)
Anti-parasitic drugs to destroy active parasites
Infection in women passing to foetus
Spiramycin therapy
CDC recommendations (here and here)
Autophagy (here and here)
Interfering with autophagy damages and destroys parasites (here and here)